Advertisement
Advertisement

FEMY

FEMY logo

Femasys Inc. Common Stock

4.08
USD
Sponsored
+0.04
+0.99%
Jun 22, 15:57 UTC -4
Closed
exchange

After-Market

4.05

-0.03
-0.71%

FEMY Earnings Reports

Positive Surprise Ratio

FEMY beat 10 of 19 last estimates.

53%

Next Report

Date of Next Report
Aug 06, 2026
Estimate for Q2 26 (Revenue/ EPS)
$745.28K
/
-$1.63
Implied change from Q1 26 (Revenue/ EPS)
+75.36%
/
+35.83%
Implied change from Q2 25 (Revenue/ EPS)
+58.91%
/
-45.67%

Femasys Inc. Common Stock earnings per share and revenue

On May 08, 2026, FEMY reported earnings of -1.20 USD per share (EPS) for Q1 26, beating the estimate of -1.83 USD, resulting in a 34.64% surprise. Revenue reached 425.00 thousand, compared to an expected 782.34 thousand, with a -45.68% difference. The market reacted with a -5.98% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -1.63 USD, with revenue projected to reach 745.28 thousand USD, implying an increase of 35.83% EPS, and increase of 75.36% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
logo
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
logo
Prenetics Global Limited Class A Ordinary Share
Report Date
Jun 10, 2026 For Q1 26
Estimate
-$1.10
Actual
-$1.61
Surprise
-45.36%
logo
Anixa Biosciences, Inc.
Report Date
Jun 10, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+21.61%
FAQ
For Q1 2026, Femasys Inc. Common Stock reported EPS of -$1.20, beating estimates by 34.64%, and revenue of $425.00K, -45.68% below expectations.
The stock price moved down -5.98%, changed from $0.43 before the earnings release to $0.40 the day after.
The next earning report is scheduled for Aug 06, 2026.
Based on 3 analysts, Femasys Inc. Common Stock is expected to report EPS of -$1.63 and revenue of $745.28K for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement